84 related articles for article (PubMed ID: 9054431)
1. Studies on intracellular translocation of apolipoprotein B in a permeabilized HepG2 system.
Macri J; Adeli K
J Biol Chem; 1997 Mar; 272(11):7328-37. PubMed ID: 9054431
[TBL] [Abstract][Full Text] [Related]
2. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
Macri J; Adeli K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
[TBL] [Abstract][Full Text] [Related]
3. Intracellular assembly and degradation of apolipoprotein B-100-containing lipoproteins in digitonin-permeabilized HEP G2 cells.
Adeli K; Wettesten M; Asp L; Mohammadi A; Macri J; Olofsson SO
J Biol Chem; 1997 Feb; 272(8):5031-9. PubMed ID: 9030566
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane.
Ingram MF; Shelness GS
J Lipid Res; 1996 Oct; 37(10):2202-14. PubMed ID: 8906597
[TBL] [Abstract][Full Text] [Related]
5. Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells.
Adeli K
J Biol Chem; 1994 Mar; 269(12):9166-75. PubMed ID: 8132654
[TBL] [Abstract][Full Text] [Related]
6. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes.
Taghibiglou C; Rudy D; Van Iderstine SC; Aiton A; Cavallo D; Cheung R; Adeli K
J Lipid Res; 2000 Apr; 41(4):499-513. PubMed ID: 10744770
[TBL] [Abstract][Full Text] [Related]
7. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
[TBL] [Abstract][Full Text] [Related]
8. A two-site model for ApoB degradation in HepG2 cells.
Wu X; Sakata N; Lele KM; Zhou M; Jiang H; Ginsberg HN
J Biol Chem; 1997 Apr; 272(17):11575-80. PubMed ID: 9111073
[TBL] [Abstract][Full Text] [Related]
9. Intracellular translocation and stability of apolipoprotein B are inversely proportional to the length of the nascent polypeptide.
Cavallo D; McLeod RS; Rudy D; Aiton A; Yao Z; Adeli K
J Biol Chem; 1998 Dec; 273(50):33397-405. PubMed ID: 9837916
[TBL] [Abstract][Full Text] [Related]
10. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.
Sakata N; Wu X; Dixon JL; Ginsberg HN
J Biol Chem; 1993 Nov; 268(31):22967-70. PubMed ID: 8226809
[TBL] [Abstract][Full Text] [Related]
11. In HepG2 cells, translocation, not degradation, determines the fate of the de novo synthesized apolipoprotein B.
Bonnardel JA; Davis RA
J Biol Chem; 1995 Dec; 270(48):28892-6. PubMed ID: 7499417
[TBL] [Abstract][Full Text] [Related]
12. Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells.
Theriault A; Wang Q; Gapor A; Adeli K
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):704-12. PubMed ID: 10073977
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools.
Davis RA; Thrift RN; Wu CC; Howell KE
J Biol Chem; 1990 Jun; 265(17):10005-11. PubMed ID: 2161829
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells.
Sakata N; Stoops JD; Dixon JL
J Biol Chem; 1999 Jun; 274(24):17068-74. PubMed ID: 10358059
[TBL] [Abstract][Full Text] [Related]
15. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
16. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
[TBL] [Abstract][Full Text] [Related]
17. The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation.
Srivastava N; Cefalu AB; Noto D; Schonfeld G; Averna M; Srivastava RA
Biochem Biophys Res Commun; 2010 Aug; 398(4):665-70. PubMed ID: 20609357
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of translocation of nascent apolipoprotein B across the endoplasmic reticulum membrane is associated with selective inhibition of the synthesis of apolipoprotein B.
Pan M; Liang Js; Fisher EA; Ginsberg HN
J Biol Chem; 2000 Sep; 275(35):27399-405. PubMed ID: 10846173
[TBL] [Abstract][Full Text] [Related]
19. Studies on degradative mechanisms mediating post-translational fragmentation of apolipoprotein B and the generation of the 70-kDa fragment.
Cavallo D; Rudy D; Mohammadi A; Macri J; Adeli K
J Biol Chem; 1999 Aug; 274(33):23135-43. PubMed ID: 10438483
[TBL] [Abstract][Full Text] [Related]
20. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
Liao W; Yeung SC; Chan L
J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
